← Back to Search

Respiratory Sensor measurements for Cystic Fibrosis

N/A
Recruiting
Research Sponsored by Singapore Bioimaging Consortium
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights

Study Summary

This trial aims to use machine learning and patient data to better predict exacerbations and deterioration for those with cardiopulmonary diseases.

Eligible Conditions
  • Cystic Fibrosis
  • Congestive Heart Failure
  • Asthma
  • Chronic Obstructive Pulmonary Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Respiration
Heart rate
Inhalation/exhalation times
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Respiratory Sensor measurementsExperimental Treatment1 Intervention
The participant will receive 2 Respiratory Sensors and 1 gateway with wireless compatibility and a welcome packet with instructions for use, a reminder description of the study purpose and procedures, and research staff contact information. Research staff will contact participants to ensure appropriate setup of the Respiratory Sensor and training on proper use. Research staff will ask the subject to place the Respiratory Sensor on the top left-side of the chest. The Respiratory Sensor continuously collects and monitors respiratory data. The participant will be instructed to change each Respiratory Sensor after 24-48 hours. Subjects will be asked to charge each Respiratory Sensor once it is removed. Subjects will exit the study upon completion of the 90-day follow-up.

Find a Location

Who is running the clinical trial?

Singapore Bioimaging ConsortiumLead Sponsor
1 Previous Clinical Trials
550 Total Patients Enrolled
Institute of Bioengineering and Bioimaging (IBB)Lead Sponsor
4 Previous Clinical Trials
622 Total Patients Enrolled
Massachusetts General HospitalOTHER
2,928 Previous Clinical Trials
13,198,295 Total Patients Enrolled
8 Trials studying Cystic Fibrosis
1,367 Patients Enrolled for Cystic Fibrosis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this trial continue to admit new participants?

"Affirmative. Clinicaltrials.gov confirms that this clinical trial, initially posted on April 1st 2022, is currently engaging in recruitment efforts. The study requires 60 participants from a single medical centre to partake in the experiment."

Answered by AI

What is the current scope of participation for this clinical trial?

"Affirmative. According to information hosted on clinicaltrials.gov, this research project is currently recruiting participants and was initially published on April 1st 2022. The study aims to recruit 60 patients from one trial site before the date of its most recent update on September 27th 2022."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Remote Monitoring of High-Risk Patients With Chronic Cardiopulmonary Diseases
2022. "Remote Monitoring of High-Risk Patients With Chronic Cardiopulmonary Diseases". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04825067.
~20 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top